“This is an important first step to allow our technology to one day help many people,” the California-based company said on its Twitter account, adding that “selection of clinical trials has not yet begun.” added. Neuralink designs devices that allow the brain to interact directly with computers.
company Neuralink billionaire owned Elon Musk announced Thursday that it has received approval from the Food and Drug Administration (FDA) to conduct human studies of brain implants.
The company advanced the FDA’s go-ahead for its first-ever human study on its Twitter account.
“This is an important first step to one day enabling our technology to help many people,” the company wrote.
In early December, Musk declared that Neuralink was ready to perform brain transplants in humans within six months.
At the time, the tycoon expressed concern that the FDA could overheat the implant (which contains the microwires in the brain tissue), which could cause leakage of chemical elements from the implant into the brain mass. pointed out.
The implant’s function is to “read” brain activity to send commands that help restore severely damaged brain function after a heart attack or amyotrophic lateral sclerosis, which severely damages the ability to communicate. Thing.
Until now, brain implants have only been developed in one direction, from the brain to the outside (usually a computer processing the signals), but the Neuralink project will allow information to be transferred in the opposite direction, back to the brain. We aim to .
Neuralink is developing two types of implants in parallel. One is to restore sight “even to those who have never regained it” and the other is to restore basic physical function to people paralyzed by spinal cord injuries.